| Amount | Holding |
|---|---|
| 0.38% | Immunomedics, Inc |
| 0.30% | Domo, Inc |
| 0.28% | MEI Pharma, Inc |
| 0.28% | Replimune Group, Inc |
| 0.26% | Calix, Inc |
| 0.26% | Kura Oncology, Inc |
| 0.26% | Quidel Corporation |
| 0.26% | Zynex, Inc |
| 0.25% | MaxLinear, Inc |
| 0.25% | USANA Health Sciences, Inc |
Diversification Rating
6 /10
Expense Ratio Rating
10 /10
Expense Rating
7 /10
Market Score
0 /10
Category Score
5 /10
Market Size
0 /10
PGIM QMA Strategic Alpha Small-Cap Growth ETF
Expenses: 0.29% (Better than 1% of similar funds)
This is an OK choice for a Small Growth US Stocks fund. See why ยป
| Amount | Holding |
|---|---|
| 0.38% | Immunomedics, Inc |
| 0.30% | Domo, Inc |
| 0.28% | MEI Pharma, Inc |
| 0.28% | Replimune Group, Inc |
| 0.26% | Calix, Inc |
| 0.26% | Kura Oncology, Inc |
| 0.26% | Quidel Corporation |
| 0.26% | Zynex, Inc |
| 0.25% | MaxLinear, Inc |
| 0.25% | USANA Health Sciences, Inc |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map